Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Serono Nears Settlement In Serostim Investigation, Sets Aside $725 Mil.

Executive Summary

Serono is setting aside $725 mil. to settle federal and state claims related to pricing and marketing practices for the AIDS wasting therapy Serostim (human growth hormone)

You may also be interested in...



Serostim $704 Mil. Settlement Is Largest For Off-Label Marketing Case

Serono's $704 mil. settlement over Serostim promotional practices marks the largest penalty ever paid by a pharmaceutical manufacturer to resolve civil and criminal investigations into off-label marketing

Serostim $704 Mil. Settlement Is Largest For Off-Label Marketing Case

Serono's $704 mil. settlement over Serostim promotional practices marks the largest penalty ever paid by a pharmaceutical manufacturer to resolve civil and criminal investigations into off-label marketing

Serostim Sales Plan Included Physician Kickbacks, Government Alleges

Serono sales managers created a plan offering physicians financial incentives to prescribe Serostim in numbers needed to achieve sales goals, an information filed by Boston U.S. Attorney Michael Sullivan alleges

Related Content

Topics

UsernamePublicRestriction

Register

PS045722

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel